Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10787studies shown

Showing 10,717-10,728 of 10,787

Drug study icon

TerminatedNCT00374543

Ziprasidone for Generalized Anxiety in people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, AnxietyDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity, Anxiety

Drug study icon

CompletedNCT00181922

Ziprasidone for Mania in Children and Adolescents With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Bipolarity

Drug study icon

CompletedNCT01172652

Ziprasidone in Bipolarity With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, AnxietyDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: VA Palo Alto Health Care System
Condition: Bipolarity, Anxiety

Drug study icon

CompletedNCT01006551

Ziprasidone in Early Onset Schizophrenia Spectrum Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 6 Years to 19 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Schizophrenia

Drug study icon

CompletedNCT00622739

Ziprasidone in Pediatric Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 10 Years to 17 Years

Countries: United States
Sponsor: Baylor College of Medicine
Condition: Bipolarity

Drug study icon

CompletedNCT00635700

Ziprasidone in the Psychosis Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 16 Years to 40 Years

Countries: United States, Canada
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

CompletedNCT00821444

Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT01293825

Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among people with Bipolarity (Zip Ad)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States
Sponsor: University Hospitals Cleveland Medical Center
Condition: Bipolarity

Drug study icon

WithdrawnNCT00786318

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 100 Years

Countries: United States
Sponsor: George Washington University
Condition: Schizophrenia

Drug study icon

CompletedNCT00340379

Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States, Egypt, India
Sponsor: Duke University
Condition: Depression, Schizophrenia

Drug study icon

CompletedNCT00221442

Zonegran in the Treatment of Binge Eating disorders Associated With Obesity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Lindner Center of HOPE
Condition: Eating disorders

Drug study icon

CompletedNCT01685996

Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.